ORCHARD THERAPEUTICS PLC Financial and Nonfinancial Liabilities, Fair Value Disclosure
ORCHARD THERAPEUTICS PLC had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $21.07 million as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2023-11-13
- 2023-09-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $21.07M.
- 2023-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $12.27M.
- 2023-03-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $6.19M.
- 2018-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2023-09-30 | $21.07M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $12.27M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $6.19M 10-Q · filed 2023-05-15 |
| 2018-12-31 | $0.00 20-F · filed 2019-03-22 |
| 2017-12-31 | $0.00 20-F · filed 2019-03-22 |